Van Eck Associates Corp Oncocyte Corp Transaction History

Van Eck Associates Corp

  • $78.1 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021
SELL
$1.38 - $2.63 $24,247 - $46,211
-17,571 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$1.2 - $1.89 $439 - $691
366 Added 2.13%
17,571 $24,000
Q2 2020

Aug 10, 2020
BUY
$1.91 - $3.45 $32,861 - $59,357
17,205 New
17,205 $33,000

Others Institutions Holding OCX

# of Institutions
3
Shares Held
399K
Call Options Held
0
Put Options Held
0
View Full List

About Oncocyte Corp

OCX Quotes by TradingView
  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $246M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email